Related Experiment Video
Updated: Aug 2, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Severe Antenatal Hypertrophic Cardiomyopathy Secondary to ACAD9-Related Mitochondrial Complex I Deficiency
Charlotte Dubucs1,2, Jacqueline Aziza1, Agnès Sartor3
1Département d'Anatomie et de Cytologie Pathologiques, Institut Universitaire du Cancer de Toulouse, Toulouse, France.
Insights
Familial hypertrophic cardiomyopathy (HCM) during pregnancy is rare. This study identified ACAD9 gene deficiency as a cause of antenatal HCM, linked to intrauterine growth restriction, guiding prenatal diagnosis.
Area of Science:
- Genetics
- Cardiology
- Metabolic Disorders
Background:
- Antenatal hypertrophic cardiomyopathy (HCM) is a rare condition.
- Familial recurrence of antenatal HCM, particularly with intrauterine growth restriction (IUGR), is infrequently documented.
Purpose of the Study:
- To describe the familial recurrence of antenatal HCM.
- To investigate the diagnostic process for antenatal HCM associated with IUGR.
- To identify potential genetic causes of antenatal HCM.
Main Methods:
- Follow-up of two pregnancies with antenatal HCM.
- Comprehensive biological assessment including metabolic and genetic analyses.
- Respiratory chain enzyme activity studies and histopathological examination.
Main Results:
- Identification of a deficiency in complex I of the respiratory chain.
- Discovery of two likely pathogenic variations in the ACAD9 gene.
- Correlation between ACAD9 deficiency, antenatal HCM, and IUGR.
Conclusions:
- ACAD9 deficiency should be considered in pregnancies with cardiomyopathy and IUGR.
- Molecular testing for ACAD9 mutations is recommended for prenatal investigations in such cases.
- Early diagnosis of antenatal HCM can be improved by considering specific genetic deficiencies.
Introduction:
Antenatal presentation of hypertrophic cardiomyopathy (HCM) is rare. We describe familial recurrence of antenatal HCM associated with intrauterine growth restriction and the diagnostic process undertaken.
Methods:
Two pregnancies with antenatal HCM were followed up. Biological assessment including metabolic analyses, genetic analyses, and respiratory chain study was performed. We describe the clinical course of these two pregnancies, antenatal manifestations as well as specific histopathological findings, and review the literature.
Results:
The assessment revealed a deficiency in complex I of the respiratory chain and two likely pathogenic variations in the ACAD9 gene.
Discussion And Conclusion:
Antenatal HCM is rare and a diagnosis is not always made. In pregnancies presenting with cardiomyopathy and intrauterine growth restriction, ACAD9 deficiency should be considered as one of the potential underlying diagnoses, and ACAD9 molecular testing should be included among other prenatal investigations.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy IV: Restrictive Cardiomyopathy
Animal Mitochondrial Genetics

